Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Gynecology · Vaginal Intraepithelial Neoplasia

What Do VaIN 1, 2, 3 and vLSIL/vHSIL Mean on Reports?

At a Glance

VaIN 1 usually corresponds to vLSIL and describes mild, low-grade changes that often clear as HPV resolves. VaIN 2 and VaIN 3 usually correspond to vHSIL, high-grade precancerous changes—not invasive vaginal cancer—that generally require treatment and close follow-up.

If you had a biopsy for a vaginal white patch (leukoplakia), your pathology report will explain the underlying cause. “Leukoplakia” describes the appearance of the patch, but the biopsy provides the actual diagnosis. If your report mentions VaIN 1, VaIN 2, VaIN 3, vLSIL, or vHSIL, it means that abnormal cell changes were found on the surface lining (mucosa) of your vagina [1].

These terms do not mean you have invasive vaginal cancer. Instead, they describe different levels of cell changes that are usually associated with the human papillomavirus (HPV) [2]. Because medical terminology has updated over time, you might see either the older “VaIN” system or the newer “SIL” system on your report, but they describe the same types of abnormal cells [3].

Making Sense of the Letters and Numbers

Both grading systems evaluate how much of the vaginal tissue thickness is taken up by abnormal cells and how altered those cells look [2].

  • VaIN stands for Vaginal Intraepithelial Neoplasia. “Intraepithelial” means the abnormal cells are confined to the top, surface layer of the vaginal lining (the epithelium) and have not spread deeper [4].
  • SIL stands for Squamous Intraepithelial Lesion, which is the newer terminology used by pathologists to describe these same surface changes [1]. The “v” simply stands for vaginal.

The two grading systems generally correspond to each other like this:

  • VaIN 1 usually corresponds to vLSIL (Low-grade SIL): This indicates mildly abnormal cell changes. It usually represents a temporary, active HPV infection that has a high chance of clearing up on its own. It is generally not considered a true precancer [2].
  • VaIN 2 and VaIN 3 usually correspond to vHSIL (High-grade SIL): These indicate moderate to severe cell changes that are often associated with a persistent high-risk HPV infection [1]. These are considered precancerous lesions because they have a higher risk of progressing to cancer over time, which is why treatment and follow-up are recommended [4].

Does This Mean I Have Cancer?

No. Both low-grade and high-grade results mean the changes are confined to the surface layer of the vagina [4]. For a diagnosis of invasive cancer, the abnormal cells would have to break through this top layer and grow into the deeper supporting tissues. A diagnosis of VaIN or vLSIL/vHSIL means that this deeper spread was not identified in the biopsy sample [5].

However, because a biopsy only samples a small piece of tissue, it cannot guarantee that an unsampled invasive focus does not exist elsewhere [5]. Your doctor will look at your pathology report alongside the visual results of your colposcopy (a magnifying exam of the vagina) to ensure the biopsy adequately captured the most concerning areas [6].

How Do These Results Affect Treatment?

The grade on your report is a major factor in deciding your next steps [7].

  • Low-grade changes (VaIN 1 / vLSIL): Because these mild changes often resolve naturally as your immune system responds to the HPV, doctors generally recommend monitoring them [7]. Monitoring often involves repeat exams, vaginal cytology (similar to a Pap smear), or HPV testing at specific intervals [8].
  • High-grade changes (VaIN 2, VaIN 3 / vHSIL): Because these have a higher risk of progression, they are typically treated to remove or destroy the abnormal cells [7]. Treatment options might include surgical excision, laser ablation, or specific topical therapies [9].

Beyond the grade, your doctor will tailor your management plan based on several other factors [7][9]:

  • Lesion size and location: Large areas or multiple scattered spots might require different approaches than a single small spot [9].
  • Previous hysterectomy: If you have had a hysterectomy, lesions can sometimes occur at or near the surgical scar at the top of the vagina (the “vaginal cuff”). The anatomy of the cuff can affect how well the area is seen, sampled, and treated [9].
  • Evaluating for invasion: If the biopsy sample was inadequate or didn’t capture the edges of a suspicious lesion, your doctor may recommend a larger excision to allow more tissue to be examined. This helps evaluate the area more thoroughly to confirm that no invasive cancer is present [7].

After any treatment or period of monitoring, long-term surveillance is important because these abnormal cells can sometimes return [7].

Symptoms to Watch For

Many VaIN lesions cause no symptoms and are found during routine screening or follow-up [10]. However, if you experience unexplained vaginal bleeding, bleeding after sex, or persistent watery or bloody discharge, contact your doctor for an evaluation [11]. While these symptoms do not automatically mean cancer, they warrant prompt clinical assessment.

Common questions in this guide

What does VaIN 1 mean on a vaginal biopsy?
VaIN 1 usually corresponds to vLSIL, or a low-grade squamous intraepithelial lesion. It describes mild changes in the surface cells, often linked to a temporary HPV infection, and is generally monitored rather than treated immediately.
What do VaIN 2 and VaIN 3 mean?
VaIN 2 and VaIN 3 usually correspond to vHSIL, or high-grade squamous intraepithelial lesion. They describe moderate to severe surface-cell changes that are considered precancerous, so treatment and closer follow-up are commonly recommended.
Does a VaIN or vHSIL result mean I have vaginal cancer?
No. VaIN and vLSIL or vHSIL describe abnormal cells confined to the surface lining, not cells that have grown into deeper tissue. Because a biopsy samples only part of a lesion, your clinician may use colposcopy or a larger sample when the area needs further evaluation.
Why are both VaIN and vLSIL or vHSIL terms used on pathology reports?
VaIN is the older grading terminology, while vLSIL and vHSIL are newer terms for vaginal squamous intraepithelial lesions. VaIN 1 usually aligns with vLSIL, and VaIN 2 or VaIN 3 usually aligns with vHSIL.
How are low-grade and high-grade vaginal changes managed?
Low-grade changes such as VaIN 1 or vLSIL are often followed with repeat examinations, vaginal cytology, or HPV testing. High-grade changes such as VaIN 2, VaIN 3, or vHSIL are commonly treated with options such as excision, laser ablation, or a topical therapy, depending on the lesion and the biopsy findings.
Can VaIN return after treatment or monitoring?
Yes, vaginal cell changes can sometimes recur after treatment or a period of observation. Long-term surveillance with the examinations or tests recommended by your clinician is important.
What symptoms should I report after a VaIN diagnosis?
Many VaIN lesions cause no symptoms, but unexplained vaginal bleeding, bleeding after sex, or persistent watery or bloody discharge should be evaluated promptly. These symptoms do not automatically mean cancer, but they warrant clinical assessment.

Get notified when new evidence is published on leukoplakia of vagina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia.

    Lamos C, Mihaljevic C, Aulmann S, et al.

    PloS one 2016; (11(12)):e0167386 doi:10.1371/journal.pone.0167386.

    PMID: 27907089
  2. 2

    The terminology of pre-invasive cervical lesions in the UK cervical screening programme.

    Herrington CS

    Cytopathology : official journal of the British Society for Clinical Cytology 2015; (26(6)):346-50 doi:10.1111/cyt.12307.

    PMID: 26767601
  3. 3

    Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study.

    Stuebs FA, Dietl AK, Koch MC, et al.

    Cancers 2023; (15(18)) doi:10.3390/cancers15184633.

    PMID: 37760600
  4. 4

    Human Papilloma Virus-Associated Squamous Neoplasia of the Lower Anogenital Tract.

    Yang EJ

    Surgical pathology clinics 2019; (12(2)):263-279 doi:10.1016/j.path.2019.02.001.

    PMID: 31097104
  5. 5

    Vaginal Intraepithelial Neoplasia: Histopathological Upgrading of Lesions and Evidence of Occult Vaginal Cancer.

    Sopracordevole F, De Piero G, Clemente N, et al.

    Journal of lower genital tract disease 2016; (20(1)):70-4 doi:10.1097/LGT.0000000000000150.

    PMID: 26461231
  6. 6

    Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology on the Detection of Vaginal Intraepithelial Neoplasia.

    Zhou Q, Zhang F, Sui L, et al.

    Cancer management and research 2020; (12()):5987-5995 doi:10.2147/CMAR.S257875.

    PMID: 32765098
  7. 7

    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.

    Kesic V, Carcopino X, Preti M, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(4)):446-461 doi:10.1136/ijgc-2022-004213.

    PMID: 36958755
  8. 8

    Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases.

    Kim MK, Lee IH, Lee KH

    Journal of gynecologic oncology 2018; (29(1)):e6 doi:10.3802/jgo.2018.29.e6.

    PMID: 29185264
  9. 9

    Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia.

    Freitas G, Costa A

    European journal of obstetrics, gynecology, and reproductive biology 2023; (284()):175-179 doi:10.1016/j.ejogrb.2023.03.014.

    PMID: 37004357
  10. 10

    Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.

    Yu D, Qu P, Liu M

    The journal of obstetrics and gynaecology research 2021; (47(5)):1624-1630 doi:10.1111/jog.14733.

    PMID: 33754436
  11. 11

    Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study.

    Stuebs FA, Koch MC, Mehlhorn G, et al.

    Archives of gynecology and obstetrics 2020; (301(3)):769-777 doi:10.1007/s00404-020-05441-5.

    PMID: 31993733

This page explains VaIN and vLSIL/vHSIL terminology for informational purposes only and does not constitute medical advice. Your gynecologist and pathologist should interpret your biopsy and recommend follow-up or treatment.